Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcella Willemsen

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
The Lancet. Oncology|June 7, 2024
Dendritic cells loaded with allogeneic tumour cell lysate plus best supportive care versus best supportive care alone in patients with pleural mesothelioma as maintenance therapy after chemotherapy (DENIM): a multicentre, open-label, randomised, phase 2/3 studyJoachim G Aerts, Robert Belderbos, Paul Baas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2024
Rintatolimod in Advanced Pancreatic Cancer Enhances Antitumor Immunity through Dendritic Cell-Mediated T-Cell ResponsesCasper W F van Eijck, Hassana El Haddaoui, Songul Kucukcelebi, et al.
Plos Computational Biology|June 23, 2026
CARGO: A cytometry analysis framework via Regularized graph optimal-transportAbida Sanjana Shemonti, Grzegorz B Gmyrek, Katrien L A Quintelier, et al.
European Journal of Cancer (Oxford, England : 1990)|July 14, 2022
Lurbinectedin shows clinical activity and immune-modulatory functions in patients with pre-treated small cell lung cancer and malignant pleural mesotheliomaDaphne W Dumoulin, Luca Cantini, Robin Cornelissen, et al.
European Journal of Cancer (Oxford, England : 1990)|November 21, 2023
FOLFIRINOX chemotherapy modulates the peripheral immune landscape in pancreatic cancer: Implications for combination therapies and early response predictionCasper W F van Eijck, Gaby Strijk, Eveline E Vietsch, et al.
Frontiers in Immunology|March 7, 2025
Short-term fasting before living kidney donation has an immune-modulatory effectChristiaan A J Oudmaijer, Daphne S J Komninos, Rutger A Ozinga, et al.
Experimental Dermatology|November 10, 2021
IFN-γ-induced PD-L1 expression on human melanocytes is impaired in vitiligoMarcella Willemsen, Gabrielle Krebbers, Esther P M Tjin, et al.
Oncotarget|October 8, 2016
Lipid phosphatase SHIP2 functions as oncogene in colorectal cancer by regulating PKB activationElmer Hoekstra, Asha M Das, Marcella Willemsen, et al.
Journal for Immunotherapy of Cancer|August 3, 2023
Adjuvant dendritic cell-based immunotherapy after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with malignant peritoneal mesothelioma: a phase II clinical trialMichelle V Dietz, Katrien L A Quintelier, Job P van Kooten, et al.
Cancer Immunology Research|May 6, 2026
Automated Computational Flow Cytometry Correlates Decreasing Neutrophil-to-Lymphocyte Ratio to Improved Survival in NSCLC After Immune Checkpoint BlockadeKatrien L A Quintelier, Maaike M Hofman, Mandy van Brakel, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
The Lancet. Oncology|June 7, 2024
Dendritic cells loaded with allogeneic tumour cell lysate plus best supportive care versus best supportive care alone in patients with pleural mesothelioma as maintenance therapy after chemotherapy (DENIM): a multicentre, open-label, randomised, phase 2/3 studyJoachim G Aerts, Robert Belderbos, Paul Baas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2024
Rintatolimod in Advanced Pancreatic Cancer Enhances Antitumor Immunity through Dendritic Cell-Mediated T-Cell ResponsesCasper W F van Eijck, Hassana El Haddaoui, Songul Kucukcelebi, et al.
Plos Computational Biology|June 23, 2026
CARGO: A cytometry analysis framework via Regularized graph optimal-transportAbida Sanjana Shemonti, Grzegorz B Gmyrek, Katrien L A Quintelier, et al.
European Journal of Cancer (Oxford, England : 1990)|July 14, 2022
Lurbinectedin shows clinical activity and immune-modulatory functions in patients with pre-treated small cell lung cancer and malignant pleural mesotheliomaDaphne W Dumoulin, Luca Cantini, Robin Cornelissen, et al.
European Journal of Cancer (Oxford, England : 1990)|November 21, 2023
FOLFIRINOX chemotherapy modulates the peripheral immune landscape in pancreatic cancer: Implications for combination therapies and early response predictionCasper W F van Eijck, Gaby Strijk, Eveline E Vietsch, et al.
Frontiers in Immunology|March 7, 2025
Short-term fasting before living kidney donation has an immune-modulatory effectChristiaan A J Oudmaijer, Daphne S J Komninos, Rutger A Ozinga, et al.
Experimental Dermatology|November 10, 2021
IFN-γ-induced PD-L1 expression on human melanocytes is impaired in vitiligoMarcella Willemsen, Gabrielle Krebbers, Esther P M Tjin, et al.
Oncotarget|October 8, 2016
Lipid phosphatase SHIP2 functions as oncogene in colorectal cancer by regulating PKB activationElmer Hoekstra, Asha M Das, Marcella Willemsen, et al.
Journal for Immunotherapy of Cancer|August 3, 2023
Adjuvant dendritic cell-based immunotherapy after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with malignant peritoneal mesothelioma: a phase II clinical trialMichelle V Dietz, Katrien L A Quintelier, Job P van Kooten, et al.
Cancer Immunology Research|May 6, 2026
Automated Computational Flow Cytometry Correlates Decreasing Neutrophil-to-Lymphocyte Ratio to Improved Survival in NSCLC After Immune Checkpoint BlockadeKatrien L A Quintelier, Maaike M Hofman, Mandy van Brakel, et al.
Pageof 3